Parker Waichman LLP

Merck hid bad Vioxx outcomes

Vioxx Maker Concealed Bad Outcomes. Vioxx maker Merck & Co. concealed heart attacks suffered by three patients during a clinical study of the now-withdrawn painkiller in a report on the study published in the New England Journal of Medicine in 2000, the journal wrote in an editorial released Thursday. The editorial, written by the journal’s […]

Vioxx

Vioxx Maker Concealed Bad Outcomes. Vioxx maker Merck & Co. concealed heart attacks suffered by three patients during a clinical study of the now-withdrawn painkiller in a report on the study published in the New England Journal of Medicine in 2000, the journal wrote in an editorial released Thursday.

The editorial, written by the journal’s editor in chief, Dr. Jeffrey M. Drazen, executive editor Dr. Gregory D. Curfman and a third doctor, also alleges the study’s authors deleted other relevant data before submitting their article for publication.

“Taken together, these inaccuracies and deletions call into question the integrity of the data on adverse cardiovascular events in this article,” the doctors wrote.

Adverse cardiovascular events include heart attacks, strokes and deaths.

Findings of the study in question have been a key part of testimony in the three product liability trials to date over the withdrawn drug, including one being deliberated Thursday by a federal jury in Texas.

In response to the journal’s editorial, Merck said “…it is important to emphasize that the company promptly and appropriately disclosed the results of the VIGOR (VIOXX Gastrointestinal Outcomes Research) study. Merck correctly communicated about the benefits and possible risks of VIOXX and extensively disclosed the VIGOR data to the scientific and medical communities, and in the press.”

In its statement, Merck added that “The VIGOR publication, which was peer-reviewed, fairly and accurately described the results of the study as of the pre-specified cutoff for analysis.  The additional events referred to in the editorial were events that were reported after the pre-specified cut-off date and therefore were not included in the primary analysis reported in the New England Journal article. Nevertheless, these additional events were disclosed to the FDA in 2000, presented publicly at the FDA’s Advisory Committee in February 2001, included in numerous press releases subsequently issued by Merck, disclosed to physicians given a copy of the article by Merck and detailed in the updated prescribing information for Vioxx.”

Correction Requested

In the journal’s editorial, the doctors alleged that excluding the three heart attacks “made certain calculations and conclusions in the article incorrect,” adding that they have asked the report’s authors to submit a correction to the journal.

Merck, in its statement, said it “looks forward to providing a more complete response to the editorial in the New England Journal of Medicine.”

The journal, in its statement labeled “Expression of Concern,” said it had made the discovery of the alleged deletions as part of preparations for the recent deposition of the executive editor of the journal in connection with Vioxx-related litigation.

The journal said Merck had submitted its manuscript both on paper and on a computer diskette, but that the journal’s pre-publication review and editing of the story were completely on the printed version of the manuscript.

The journal said it did not review the diskette until Oct. 5, 2004, several days after Vioxx was pulled from the market after other research showed the popular arthritis drug doubled risks of heart attacks and stroke with long-term use.

“In reviewing the diskette, we learned that data on cardiovascular events had been deleted from the manuscript before it was submitted,” the journal said.

One of the study’s authors was Dr. Alise Reicin, Merck’s vice president for clinical research. Reicin on Wednesday testified in the Houston trial that the company never misled doctors and the public about studies linking heart attacks to Vioxx.

The company now faces at least 7,000 lawsuits over Vioxx and legal liability some analysts have estimated at up to $50 billion. Those problems were part of the reason Merck last week announced plans to cut 7,000 jobs and close eight manufacturing and research facilities around the world as the first step in a sweeping reorganization.

Need Legal Help Regarding Vioxx?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Parker Waichman LLP helped me with my case. It all started with a visit from Jorge Peniche who was extremely professional, courteous and detailed with my case. All of my questions and concerns were addressed. I was provided with evidence, my emails, phone calls and inquiries were addressed in a timely fashion with great guidance and care. I am very grateful and appreciative as I had never been through this experience. They were great, a special thanks to Jorge Peniche, who was amazing, the lawyer in my case, Denny Tang and the nurse at the firm. Greatly appreciated. Kindly, Kathy
Kathy M
4 years ago
5 Star Reviews 150
Parker Waichman handled my case very well and obtained a fantastic result. The team representing me had me informed of the progress from begining to end. My attorney Joonho fought very hard for me and his paralegal Meredith Ippolito was exceptional fielding my many questions and making sure everything was getting done as it was supposed too. I cant thank my PW team enough for handling my case professionally and for the outstanding result!
Paul Ulitsky
a year ago
5 Star Reviews 150
Mindy Gallagher
a year ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038